Search Results - "Agid, Y."

Neurodegenerative disorders: Are we wrong? by Agid, Y.

“…It is not obvious how to define a neurodegenerative disorder. There are several challenging questions: How should the diagnosis be made? How can we be sure…”
Get full text

Jacques Glowinski by Agid, Y.

Get full text

Progress in the neurosciences and the training of medical students by Agid, Y.

Get full text

Subconsciousness, emotional disorders, and basal ganglia by Agid, Y.

Get full text

Levodopa : Is toxicity a myth? by AGID, Y

“…Whether a drug such as levodopa, which is prescribed for long periods, may be toxic is a legitimate and even indispensable question. The problem is no…”
Get full text

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease by Ibáñez, P, Bonnet, A-M, Débarges, B, Lohmann, E, Tison, F, Pollak, P, Agid, Y, Dürr, A, Brice, A

“…The alpha-synuclein gene (SNCA) has been implicated in autosomal dominant forms of Parkinson's disease. We screened 119 individuals from families with this…”
Get full text

Foreword. History of the frontal lobe by Bossi, L, Agid, Y

Get full text

Neurosurgery in Parkinson disease: a distressed mind in a repaired body? by Schüpbach, M, Gargiulo, M, Welter, M L, Mallet, L, Béhar, C, Houeto, J L, Maltête, D, Mesnage, V, Agid, Y

“…To prospectively evaluate the impact of subthalamic nucleus (STN) stimulation on social adjustment in patients with Parkinson disease (PD). Before and 18 to 24…”
Get full text

Behavior, brain and astrocytes by Fan, X., Agid, Y.

Get full text

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up by Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J.-L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M. I., Quinn, N. P., Speelman, J. D., Guridi, J., Zamarbide, I., Gironell, A., Molet, J., Pascual-Sedano, B., Pidoux, B., Bonnet, A. M., Agid, Y., Xie, J., Benabid, A.-L., Lozano, A. M., Saint-Cyr, J., Romito, L., Contarino, M. F., Scerrati, M., Fraix, V., Van Blercom, N.

“…Deep brain stimulation (DBS) is associated with significant improvement of motor complications in patients with severe Parkinson's disease after some 6–12…”
Get full text

Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia by Vidailhet, Marie, Vercueil, Laurent, Houeto, Jean-Luc, Krystkowiak, Pierre, Benabid, Alim-Louis, Cornu, Philippe, Lagrange, Christelle, Tézenas du Montcel, Sophie, Dormont, Didier, Grand, Sylvie, Blond, Serge, Detante, Olivier, Pillon, Bernard, Ardouin, Claire, Agid, Yves, Destée, Alain, Pollak, Pierre

“…In a series of 22 patients with primary generalized dystonia refractory to medical therapy, bilateral pallidal stimulation significantly improved movement and…”
Get full text

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease by DAMIER, P, HIRSCH, E. C, AGID, Y, GRAYBIEL, A. M

“…To achieve accuracy in studying the patterns of loss of midbrain dopamine-containing neurons in Parkinson's disease, we used compartmental patterns of…”
Get full text

Restoration of normal motor control in Parkinson's disease during REM sleep by De Cock, Valérie Cochen, Vidailhet, Marie, Leu, Smaranda, Texeira, Antonio, Apartis, Emmanuelle, Elbaz, Alexis, Roze, Emmanuel, Willer, Jean Claude, Derenne, Jean Philippe, Agid, Yves, Arnulf, Isabelle

“…Although normal subjects do not move during REM sleep, patients with Parkinson's disease may experience REM sleep behaviour disorder (RBD). The characteristics…”
Get full text

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population by SAAD, Mohamad, LESAGE, Suzanne, POLLAK, Pierre, DAMIER, Philippe, TISON, François, SILBURN, Peter A, TZOURIO, Christophe, FORIANI, Sylvie, LORIOT, Marie-Anne, GIROUD, Maurice, HELMER, Catherine, PORTET, Florence, SAINT-PIERRE, Aude, AMOUYEL, Philippe, LATHROP, Mark, ELBAZ, Alexis, DURR, Alexandra, MARTINEZ, Maria, BRICE, Alexis, CORVOL, Jean-Christophe, ZELENIKA, Diana, LAMBERT, Jean-Charles, VIDAILHET, Marie, MELLICK, George D, LOHMANN, Ebba, DURIF, Franck

“…We performed a three-stage genome-wide association study (GWAS) to identify common Parkinson's disease (PD) risk variants in the European population. The…”
Get full text

Clinical predictive factors of subthalamic stimulation in Parkinson's disease by WELTER, M. L, HOUETO, J. L, AGID, Y, TEZENAS DU MONTCEL, S, MESNAGE, V, BONNET, A. M, PILLON, B, ARNULF, I, PIDOUX, B, DORMONT, D, CORNU, P

“…High-frequency stimulation of the subthalamic nucleus (STN) constitutes one of the most effective treatments for advanced forms of Parkinson's disease. The…”
Get full text

Neurosurgery at an earlier stage of Parkinson disease : A randomized, controlled trial by SCHÜPBACH, W. M. M, MALTETE, D, PIDOUX, B, NAVARRO, S, DORMONT, D, CORNU, P, AGID, Y, HOUETO, J. L, TEZENAS DU MONTCEL, S, MALLET, L, WELTER, M. L, GARGIULO, M, BEHAR, C, BONNET, A. M, CZERNECKI, V

“…Stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson disease (PD) and is currently performed after a mean disease duration…”
Get full text

Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease by Chastan, N., Westby, G. W. M., Yelnik, J., Bardinet, E., Do, M. C., Agid, Y., Welter, M. L.

“…The physiopathology of gait and balance disorders in Parkinson's disease patients is still poorly understood. Levodopa treatment and subthalamic nucleus (STN)…”
Get full text

Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up by Schüpbach, W M M, Chastan, N, Welter, M L, Houeto, J L, Mesnage, V, Bonnet, A M, Czernecki, V, Maltête, D, Hartmann, A, Mallet, L, Pidoux, B, Dormont, D, Navarro, S, Cornu, P, Mallet, A, Agid, Y

“…Background: The short term benefits of bilateral stimulation of the subthalamic nucleus (STN) in patients with advanced levodopa responsive Parkinson’s disease…”
Get full text

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry by Damier, P, Hirsch, E C, Agid, Y, Graybiel, A M

“…Parkinson's disease is characterized by massive degeneration of dopamine-containing neurons in the midbrain. However, the vulnerability of these neurons is…”
Get full text

Parkinson's disease and sleepiness: An integral part of PD by ARNULF, I, KONOFAL, E, MERINO-ANDREU, M, HOUETO, J. L, MESNAGE, V, WELTER, M. L, LACOMBLEZ, L, GOLMARD, J. L, DERENNE, J. P, AGID, Y

“…To investigate the potential causes of excessive daytime sleepiness in patients with PD-poor sleep quality, abnormal sleep-wakefulness control, and treatment…”
Get full text